Delivery Order SPE2DB25D3201-SPE2DB25FNRFW

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluorouracil 0.5% cream in 30 gram quantities. The $2,352.07 firm fixed-price delivery order was made under a broader Indefinite Delivery Contract (IDC) with Cencora, Inc. (doing business as Amerisourcebergen) valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluorouracil 0.5% Cream, a medication used for the treatment of various skin conditions. The contract has a ceiling value of $1,393.18 and runs through March 30, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award SPE2DB20D3103|SPE2DB23FM7U5 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560272435 - Fluorouracil 5% Cream 40GM. The $1,385.83 firm fixed price delivery order has a completion date of March 16, 2023 and was awarded on March 15, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: KABZK8W6PQT3) is for the delivery of Fluorouracil 5% Cream, 40 grams. The $1,460.21 firm-fixed-price Delivery Order was issued by the Defense Logistics Agency (DLA) on January 6, 2025, with an ultimate completion date of January 7, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluorouracil 5% Cream 40GM. The contract has a potential value of $2,116.86 and a completion date of February 29, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp is a prime contractor for DLA, providing a wide range of pharmaceutical products and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,390.06 and covers the delivery of Fluorouracil 0.5% Cream, a pharmaceutical product, with an ultimate completion date of April 5, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization...
The federal contract award SPE2DB25D3020|SPE2DB25FWGAB was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 40 gram tubes of 5% Fluorouracil cream. The contract has a ceiling value of $1,002.17 and a completion date of February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,274.86 firm fixed-price contract is for the delivery of 4555497530 - Fluorouracil 0.5% Cream 30GM, a pharmaceutical product. The contract has a completion date of November 23, 2021 and was awarded on November 22, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4556874122 Fluorouracil 0.5% Cream 30GM. The firm-fixed-price delivery order, valued at $1,385.28, has an ultimate completion date of April 13, 2022. The contract was awarded on April 12, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.92 firm fixed-price delivery order is for the supply of Fluorouracil 5% topical solution, a medication used for the treatment of certain skin conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNRFW
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,951.80 firm fixed-price delivery order is for the supply of FLUOROURACIL 5% CREAM 40GM, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be one of many that fall under the larger DLA IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/23/25, 9:45 AM